1. Home
  2. OPAL vs CALC Comparison

OPAL vs CALC Comparison

Compare OPAL & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

N/A

Current Price

$2.18

Market Cap

78.3M

Sector

Utilities

ML Signal

N/A

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

N/A

Current Price

$5.60

Market Cap

88.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPAL
CALC
Founded
1998
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.3M
88.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OPAL
CALC
Price
$2.18
$5.60
Analyst Decision
Sell
Strong Buy
Analyst Count
4
1
Target Price
$2.81
$16.00
AVG Volume (30 Days)
386.4K
105.2K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$329,243,000.00
N/A
Revenue This Year
$17.15
N/A
Revenue Next Year
$22.04
N/A
P/E Ratio
$95.04
N/A
Revenue Growth
7.26
N/A
52 Week Low
$1.26
$1.42
52 Week High
$4.08
$7.20

Technical Indicators

Market Signals
Indicator
OPAL
CALC
Relative Strength Index (RSI) 45.03 53.61
Support Level $2.12 $5.52
Resistance Level $2.87 $7.20
Average True Range (ATR) 0.19 0.72
MACD -0.03 -0.10
Stochastic Oscillator 27.01 38.75

Price Performance

Historical Comparison
OPAL
CALC

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: